Literature DB >> 19317998

Surgical contribution to recurrence-free survival in patients with macrovascular-invasion-negative hepatocellular carcinoma.

Shinji Tanaka1, Kaoru Mogushi, Mahmut Yasen, Norio Noguchi, Atsushi Kudo, Toshiaki Kurokawa, Noriaki Nakamura, Johji Inazawa, Hiroshi Tanaka, Shigeki Arii.   

Abstract

BACKGROUND: Macroscopic vascular invasion (MVI) is a well-known indicator of recurrence of hepatocellular carcinoma (HCC) even after curative hepatectomy, but the clinicopathologic and molecular features of the recurrence remain unclear in MVI-negative HCC. STUDY
DESIGN: Two hundred seven consecutive patients with confirmed primary MVI-negative HCC were retrospectively assessed after curative resection, with special emphasis on the importance of anatomically systematized hepatectomy. HCC tissues were also analyzed for genome-wide gene expression profile of each tumor using a microarray technique.
RESULTS: Univariant analysis of HCC recurrence revealed multiple tumors (p < 0.001), moderate to poor differentiation (p = 0.044), Child-Pugh B/C (p = 0.047), alpha-fetoprotein elevation (p = 0.007), and nonanatomic hepatectomy (p = 0.010) as risk factors. According to Cox hazard multivariant analysis, multiple tumors (p = 0.002), alpha-fetoprotein elevation (p < 0.001), and nonanatomic hepatectomy (p = 0.002) were identified as independent factors of the recurrence. In the recurrent cases after anatomic hepatectomy for HCC, local recurrence was significantly infrequent compared with those after nonanatomic hepatectomy (p < 0.001). Network expression analysis using cDNA microarray revealed distinct signaling pathways of epithelial-mesenchymal transitions are associated with recurrence after anatomically systematized hepatectomy.
CONCLUSIONS: Anatomically systematized hepatectomy might contribute to recurrence-free survival of HCC patients of HCC without MVI. Local recurrence could be mostly averted by anatomic hepatectomy, although specific epithelial-mesenchymal transitions signaling might regulate the biologic aggressiveness of HCC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19317998     DOI: 10.1016/j.jamcollsurg.2008.10.031

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  11 in total

1.  Successful Anatomic Resection of Tumor-Bearing Portal Territory Delays Long-Term Stage Progression of Hepatocellular Carcinoma.

Authors:  Junichi Shindoh; Yuta Kobayashi; Ryosuke Umino; Kazutaka Kojima; Satoshi Okubo; Masaji Hashimoto
Journal:  Ann Surg Oncol       Date:  2020-07-25       Impact factor: 5.344

2.  Villin 1 is a predictive factor for the recurrence of high serum alpha-fetoprotein-associated hepatocellular carcinoma after hepatectomy.

Authors:  Maimaiti Xieraili; Mahmut Yasen; Kaoru Mogushi; Gulanbar Obulhasim; Abudureheman Mayinuer; Arihiro Aihara; Shinji Tanaka; Hiroshi Mizushima; Hiroshi Tanaka; Shigeki Arii
Journal:  Cancer Sci       Date:  2012-05-25       Impact factor: 6.716

3.  Evaluation of the seventh edition of the American Joint Committee on Cancer tumour-node-metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system.

Authors:  Albert C Y Chan; Sheung Tat Fan; Ronnie T P Poon; Tan To Cheung; Kenneth S H Chok; See Ching Chan; Chung Mau Lo
Journal:  HPB (Oxford)       Date:  2012-12-02       Impact factor: 3.647

4.  Risk factors of post-operative recurrence and adequate surgical approach to improve long-term outcomes of hepatocellular carcinoma.

Authors:  Junichi Shindoh; Kiyoshi Hasegawa; Yosuke Inoue; Takeaki Ishizawa; Rihito Nagata; Taku Aoki; Yoshihiro Sakamoto; Yasuhiko Sugawara; Masatoshi Makuuchi; Norihiro Kokudo
Journal:  HPB (Oxford)       Date:  2012-08-26       Impact factor: 3.647

5.  Correlation of LAPTM4B polymorphisms with hepatocellular carcinoma in Chinese patients.

Authors:  Guojun Zhai; Hua Yang; Xiaoxu Ji; Fuxia Xiong; Jing Su; Michael A McNutt; Xuan Li
Journal:  Med Oncol       Date:  2011-12-30       Impact factor: 3.064

Review 6.  Meta-analysis of anatomic resection versus nonanatomic resection for hepatocellular carcinoma.

Authors:  Yanming Zhou; Donghui Xu; Lupeng Wu; Bin Li
Journal:  Langenbecks Arch Surg       Date:  2011-04-08       Impact factor: 3.445

7.  LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.

Authors:  Hua Yang; Fu Xia Xiong; Ming Lin; Yu Yang; Xiu Nie; Rou Li Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-19       Impact factor: 4.553

8.  Reduced expression of ASS is closely related to clinicopathological features and post-resectional survival of hepatocellular carcinoma.

Authors:  Hua Yang; Ming Lin; Fu Xia Xiong; Yu Yang; Xiu Nie; Rou Li Zhou
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

9.  iCOD: an integrated clinical omics database based on the systems-pathology view of disease.

Authors:  Kazuro Shimokawa; Kaoru Mogushi; Satoshi Shoji; Atsuko Hiraishi; Keisuke Ido; Hiroshi Mizushima; Hiroshi Tanaka
Journal:  BMC Genomics       Date:  2010-12-02       Impact factor: 3.969

10.  Prognostic value of precise hepatic pedicle dissection in anatomical resection for patients with hepatocellular carcinoma.

Authors:  Hui Zhao; Wen-Zhou Ding; Hong Wang; Shen Gu; Xiao-Peng Yan; Shi-Quan Sun; Liang Mao; Hui-Han Jin; Yu-Dong Qiu
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.